<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(4)</volume><submitter>Feser R</submitter><pubmed_abstract>MicroRNA (miRNA/miR) 526 b- and miR655-overexpressed tumor cell-free secretions regulate the breast cancer tumor microenvironment (TME) by promoting tumor-associated angiogenesis, oxidative stress, and hypoxic responses. Additionally, premature miRNA (pri-miR526b and pri-miR655) are established breast cancer blood biomarkers. However, the mechanisms of how these miRNAs regulate the TME has yet to be investigated. Mass spectrometry analysis of miRNA-overexpressed cell lines MCF7-miR526b, MCF7-miR655, and miRNA-low MCF7-Mock cell-free secretomes identified 34 differentially expressed proteins coded by eight genes. In both miRNA-high cell secretomes, four markers are upregulated: &lt;i>YWHAB&lt;/i>, &lt;i>SFN&lt;/i>, &lt;i>TXNDC12&lt;/i>, and &lt;i>MYL6B,&lt;/i> and four are downregulated: &lt;i>PEA15&lt;/i>, &lt;i>PRDX4&lt;/i></pubmed_abstract><journal>Heliyon</journal><pagination>e15421</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10148110</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Breast cancer cell secretome analysis to decipher miRNA regulating the tumor microenvironment and discover potential biomarkers.</pubmed_title><pmcid>PMC10148110</pmcid><pubmed_authors>Feser R</pubmed_authors><pubmed_authors>Nault B</pubmed_authors><pubmed_authors>Chen VC</pubmed_authors><pubmed_authors>Opperman RM</pubmed_authors><pubmed_authors>Majumder M</pubmed_authors><pubmed_authors>Maiti S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Breast cancer cell secretome analysis to decipher miRNA regulating the tumor microenvironment and discover potential biomarkers.</name><description>MicroRNA (miRNA/miR) 526 b- and miR655-overexpressed tumor cell-free secretions regulate the breast cancer tumor microenvironment (TME) by promoting tumor-associated angiogenesis, oxidative stress, and hypoxic responses. Additionally, premature miRNA (pri-miR526b and pri-miR655) are established breast cancer blood biomarkers. However, the mechanisms of how these miRNAs regulate the TME has yet to be investigated. Mass spectrometry analysis of miRNA-overexpressed cell lines MCF7-miR526b, MCF7-miR655, and miRNA-low MCF7-Mock cell-free secretomes identified 34 differentially expressed proteins coded by eight genes. In both miRNA-high cell secretomes, four markers are upregulated: &lt;i>YWHAB&lt;/i>, &lt;i>SFN&lt;/i>, &lt;i>TXNDC12&lt;/i>, and &lt;i>MYL6B,&lt;/i> and four are downregulated: &lt;i>PEA15&lt;/i>, &lt;i>PRDX4&lt;/i></description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2026-04-08T14:18:00.832Z</modification><creation>2025-04-04T14:18:31.102Z</creation></dates><accession>S-EPMC10148110</accession><cross_references><pubmed>37128318</pubmed><doi>10.1016/j.heliyon.2023.e15421</doi></cross_references></HashMap>